FDA Approved: AFREZZA — Supplemental Application (Mannkind Corporation)

View source ↗

Summary

FDA approves a supplemental application for AFREZZA (insulin human) from MannKind Corporation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Afrezza (Technosphere insulin)

Snippet

SUPPL AP for AFREZZA (INSULIN HUMAN)